nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—NGF—Frs2-mediated activation—IL6—bile duct cancer	0.0136	0.0136	CbGpPWpGaD
Clenbuterol—NGF—Prolonged ERK activation events—HRAS—bile duct cancer	0.0134	0.0134	CbGpPWpGaD
Clenbuterol—NGF—Signalling to RAS—KRAS—bile duct cancer	0.0131	0.0131	CbGpPWpGaD
Clenbuterol—NGF—Prolonged ERK activation events—IL6—bile duct cancer	0.0128	0.0128	CbGpPWpGaD
Clenbuterol—NGF—Trk receptor signaling mediated by PI3K and PLC-gamma—KRAS—bile duct cancer	0.0125	0.0125	CbGpPWpGaD
Clenbuterol—NGF—Signalling to ERKs—NRAS—bile duct cancer	0.0124	0.0124	CbGpPWpGaD
Clenbuterol—ADRB1—Endothelin Pathways—GNAS—bile duct cancer	0.0115	0.0115	CbGpPWpGaD
Clenbuterol—TNF—Overview of nanoparticle effects—PTGS2—bile duct cancer	0.0113	0.0113	CbGpPWpGaD
Clenbuterol—NGF—Signalling to RAS—HRAS—bile duct cancer	0.0111	0.0111	CbGpPWpGaD
Clenbuterol—NGF—Signalling to ERKs—KRAS—bile duct cancer	0.0107	0.0107	CbGpPWpGaD
Clenbuterol—NGF—Signalling to RAS—IL6—bile duct cancer	0.0107	0.0107	CbGpPWpGaD
Clenbuterol—NGF—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—bile duct cancer	0.0106	0.0106	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—TGFBR2—bile duct cancer	0.0105	0.0105	CbGpPWpGaD
Clenbuterol—ADRB2—Arf6 signaling events—HGF—bile duct cancer	0.0102	0.0102	CbGpPWpGaD
Clenbuterol—NGF—SHP2 signaling—NRAS—bile duct cancer	0.00992	0.00992	CbGpPWpGaD
Clenbuterol—NGF—Neurotrophic factor-mediated Trk receptor signaling—NRAS—bile duct cancer	0.00953	0.00953	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—TGFBR2—bile duct cancer	0.00949	0.00949	CbGpPWpGaD
Clenbuterol—TNF—Matrix Metalloproteinases—MMP2—bile duct cancer	0.00919	0.00919	CbGpPWpGaD
Clenbuterol—NGF—Signalling to ERKs—HRAS—bile duct cancer	0.00906	0.00906	CbGpPWpGaD
Clenbuterol—TNF—IL23-mediated signaling events—NOS2—bile duct cancer	0.00905	0.00905	CbGpPWpGaD
Clenbuterol—NGF—SHP2 signaling—EGFR—bile duct cancer	0.00904	0.00904	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—SMAD4—bile duct cancer	0.00899	0.00899	CbGpPWpGaD
Clenbuterol—TNF—amb2 Integrin signaling—MMP2—bile duct cancer	0.00872	0.00872	CbGpPWpGaD
Clenbuterol—NGF—Signalling to ERKs—IL6—bile duct cancer	0.00867	0.00867	CbGpPWpGaD
Clenbuterol—NGF—SHP2 signaling—KRAS—bile duct cancer	0.00854	0.00854	CbGpPWpGaD
Clenbuterol—NGF—PI3K/AKT activation—ERBB2—bile duct cancer	0.00837	0.00837	CbGpPWpGaD
Clenbuterol—NGF—Neurotrophic factor-mediated Trk receptor signaling—KRAS—bile duct cancer	0.0082	0.0082	CbGpPWpGaD
Clenbuterol—ADRB2—Arf6 signaling events—MET—bile duct cancer	0.00803	0.00803	CbGpPWpGaD
Clenbuterol—NGF—SHP2 signaling—HRAS—bile duct cancer	0.00726	0.00726	CbGpPWpGaD
Clenbuterol—NGF—Neurotrophic factor-mediated Trk receptor signaling—HRAS—bile duct cancer	0.00697	0.00697	CbGpPWpGaD
Clenbuterol—NGF—SHP2 signaling—IL6—bile duct cancer	0.00695	0.00695	CbGpPWpGaD
Clenbuterol—TNF—Matrix Metalloproteinases—MMP9—bile duct cancer	0.0069	0.0069	CbGpPWpGaD
Clenbuterol—ADRB3—G alpha (s) signalling events—GNAS—bile duct cancer	0.00669	0.00669	CbGpPWpGaD
Clenbuterol—NGF—p75(NTR)-mediated signaling—TP53—bile duct cancer	0.00661	0.00661	CbGpPWpGaD
Clenbuterol—TNF—amb2 Integrin signaling—MMP9—bile duct cancer	0.00656	0.00656	CbGpPWpGaD
Clenbuterol—TNF—IL27-mediated signaling events—TGFB1—bile duct cancer	0.00638	0.00638	CbGpPWpGaD
Clenbuterol—TNF—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—bile duct cancer	0.00638	0.00638	CbGpPWpGaD
Clenbuterol—TNF—Cytokines and Inflammatory Response—TGFB1—bile duct cancer	0.00619	0.00619	CbGpPWpGaD
Clenbuterol—TNF—Overview of nanoparticle effects—IL6—bile duct cancer	0.00618	0.00618	CbGpPWpGaD
Clenbuterol—TNF—Angiopoietin receptor Tie2-mediated signaling—MMP2—bile duct cancer	0.0061	0.0061	CbGpPWpGaD
Clenbuterol—NGF—PI3K/AKT activation—EGFR—bile duct cancer	0.0058	0.0058	CbGpPWpGaD
Clenbuterol—ADRB3—Calcium Regulation in the Cardiac Cell—GNAS—bile duct cancer	0.00578	0.00578	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—PTGS2—bile duct cancer	0.00559	0.00559	CbGpPWpGaD
Clenbuterol—TNF—Transcription factor regulation in adipogenesis—IL6—bile duct cancer	0.00549	0.00549	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—ROBO2—bile duct cancer	0.00549	0.00549	CbGpPWpGaD
Clenbuterol—TNF—TWEAK Signaling Pathway—MMP9—bile duct cancer	0.00527	0.00527	CbGpPWpGaD
Clenbuterol—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—bile duct cancer	0.00523	0.00523	CbGpPWpGaD
Clenbuterol—TNF—IL27-mediated signaling events—IL6—bile duct cancer	0.00481	0.00481	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—ERBB2—bile duct cancer	0.00473	0.00473	CbGpPWpGaD
Clenbuterol—TNF—Cytokines and Inflammatory Response—IL6—bile duct cancer	0.00466	0.00466	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.00435	0.00435	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—NRAS—bile duct cancer	0.00424	0.00424	CbGpPWpGaD
Clenbuterol—TNF—amb2 Integrin signaling—IL6—bile duct cancer	0.00407	0.00407	CbGpPWpGaD
Clenbuterol—ADRB2—Arf6 signaling events—EGFR—bile duct cancer	0.00407	0.00407	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	0.00404	0.00404	CbGpPWpGaD
Clenbuterol—ADRB1—G alpha (s) signalling events—GNAS—bile duct cancer	0.00397	0.00397	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.00396	0.00396	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	0.00396	0.00396	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—TGFB1—bile duct cancer	0.00394	0.00394	CbGpPWpGaD
Clenbuterol—ADRB2—G alpha (s) signalling events—GNAS—bile duct cancer	0.00388	0.00388	CbGpPWpGaD
Clenbuterol—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—bile duct cancer	0.00388	0.00388	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—EGFR—bile duct cancer	0.00386	0.00386	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TGFBR2—bile duct cancer	0.00383	0.00383	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.00374	0.00374	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—KRAS—bile duct cancer	0.00365	0.00365	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—ERBB2—bile duct cancer	0.00364	0.00364	CbGpPWpGaD
Clenbuterol—TNF—IL23-mediated signaling events—IL6—bile duct cancer	0.00363	0.00363	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—NRAS—bile duct cancer	0.0036	0.0036	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—NOS2—bile duct cancer	0.00358	0.00358	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—TGFB1—bile duct cancer	0.00356	0.00356	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.00355	0.00355	CbGpPWpGaD
Clenbuterol—NGF—BDNF signaling pathway—HRAS—bile duct cancer	0.00351	0.00351	CbGpPWpGaD
Clenbuterol—TNF—Cardiac Hypertrophic Response—TGFB1—bile duct cancer	0.0035	0.0035	CbGpPWpGaD
Clenbuterol—ADRB1—Calcium Regulation in the Cardiac Cell—GNAS—bile duct cancer	0.00343	0.00343	CbGpPWpGaD
Clenbuterol—ADRB2—Calcium Regulation in the Cardiac Cell—GNAS—bile duct cancer	0.00335	0.00335	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—PTGS2—bile duct cancer	0.00333	0.00333	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—EGFR—bile duct cancer	0.00328	0.00328	CbGpPWpGaD
Clenbuterol—TNF—TWEAK Signaling Pathway—IL6—bile duct cancer	0.00328	0.00328	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.00327	0.00327	CbGpPWpGaD
Clenbuterol—TNF—Downstream signaling in naïve CD8+ T cells—NRAS—bile duct cancer	0.00326	0.00326	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—TP53—bile duct cancer	0.00324	0.00324	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—RNF43—bile duct cancer	0.00323	0.00323	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.00318	0.00318	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—IL6—bile duct cancer	0.00315	0.00315	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—KRAS—bile duct cancer	0.0031	0.0031	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—bile duct cancer	0.00307	0.00307	CbGpPWpGaD
Clenbuterol—CYP1A1—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.00287	0.00287	CbGpPWpGaD
Clenbuterol—TNF—Downstream signaling in naïve CD8+ T cells—KRAS—bile duct cancer	0.0028	0.0028	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—IL6—bile duct cancer	0.0028	0.0028	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—HRAS—bile duct cancer	0.0028	0.0028	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—NRAS—bile duct cancer	0.00277	0.00277	CbGpPWpGaD
Clenbuterol—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—bile duct cancer	0.00268	0.00268	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—HRAS—bile duct cancer	0.00263	0.00263	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—PTGS2—bile duct cancer	0.00263	0.00263	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—TGFB1—bile duct cancer	0.00262	0.00262	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—EGFR—bile duct cancer	0.00252	0.00252	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—IL6—bile duct cancer	0.00252	0.00252	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—NRAS—bile duct cancer	0.0025	0.0025	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—bile duct cancer	0.0025	0.0025	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—TP53—bile duct cancer	0.00249	0.00249	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—GNAS—bile duct cancer	0.00243	0.00243	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.00239	0.00239	CbGpPWpGaD
Clenbuterol—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—bile duct cancer	0.00238	0.00238	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—KRAS—bile duct cancer	0.00238	0.00238	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—MMP9—bile duct cancer	0.00231	0.00231	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—IL6—bile duct cancer	0.00228	0.00228	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.00226	0.00226	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	0.00222	0.00222	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	0.00218	0.00218	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.00218	0.00218	CbGpPWpGaD
Clenbuterol—TNF—Alzheimers Disease—TP53—bile duct cancer	0.00216	0.00216	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—KRAS—bile duct cancer	0.00215	0.00215	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TP53—bile duct cancer	0.00206	0.00206	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.00205	0.00205	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—HRAS—bile duct cancer	0.00203	0.00203	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bile duct cancer	0.00196	0.00196	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—IL6—bile duct cancer	0.00194	0.00194	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—TGFB1—bile duct cancer	0.0019	0.0019	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—EGFR—bile duct cancer	0.00187	0.00187	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.00183	0.00183	CbGpPWpGaD
Clenbuterol—CYP1A2—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.00183	0.00183	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—HRAS—bile duct cancer	0.00183	0.00183	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—IL6—bile duct cancer	0.00181	0.00181	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.00179	0.00179	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—TGFB1—bile duct cancer	0.00176	0.00176	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—IL6—bile duct cancer	0.00175	0.00175	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.00175	0.00175	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RNF43—bile duct cancer	0.00167	0.00167	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—IL6—bile duct cancer	0.00161	0.00161	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—FAR2—bile duct cancer	0.00158	0.00158	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—TP53—bile duct cancer	0.00157	0.00157	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—NRAS—bile duct cancer	0.00154	0.00154	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—SMAD4—bile duct cancer	0.00153	0.00153	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.00152	0.00152	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00149	0.00149	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TGFBR2—bile duct cancer	0.00148	0.00148	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—GNAS—bile duct cancer	0.00144	0.00144	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TGFB1—bile duct cancer	0.00143	0.00143	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IL6—bile duct cancer	0.00143	0.00143	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—GNAS—bile duct cancer	0.00142	0.00142	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	0.00141	0.00141	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—GNAS—bile duct cancer	0.00141	0.00141	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—EGFR—bile duct cancer	0.00141	0.00141	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SMAD4—bile duct cancer	0.0014	0.0014	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	0.00139	0.00139	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.00139	0.00139	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—GNAS—bile duct cancer	0.00137	0.00137	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—KRAS—bile duct cancer	0.00133	0.00133	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—IL6—bile duct cancer	0.00133	0.00133	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.00131	0.00131	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.00129	0.00129	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.00127	0.00127	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TP53—bile duct cancer	0.00126	0.00126	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—IL6—bile duct cancer	0.00126	0.00126	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—GNAS—bile duct cancer	0.00125	0.00125	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.0012	0.0012	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TP53—bile duct cancer	0.00118	0.00118	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MET—bile duct cancer	0.00117	0.00117	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL6—bile duct cancer	0.00115	0.00115	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.00111	0.00111	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.00107	0.00107	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—FAR2—bile duct cancer	0.00101	0.00101	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RNF43—bile duct cancer	0.000991	0.000991	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP2—bile duct cancer	0.000977	0.000977	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RNF43—bile duct cancer	0.00097	0.00097	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00095	0.00095	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—ERBB2—bile duct cancer	0.000856	0.000856	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—GNAS—bile duct cancer	0.000815	0.000815	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—GNAS—bile duct cancer	0.000797	0.000797	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ERBB2—bile duct cancer	0.000782	0.000782	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—IDH2—bile duct cancer	0.000772	0.000772	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TGFBR2—bile duct cancer	0.000763	0.000763	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—GNAS—bile duct cancer	0.00074	0.00074	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—GNAS—bile duct cancer	0.000736	0.000736	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP9—bile duct cancer	0.000734	0.000734	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—GNAS—bile duct cancer	0.000724	0.000724	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SMAD4—bile duct cancer	0.000723	0.000723	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MMP9—bile duct cancer	0.000671	0.000671	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—IDH1—bile duct cancer	0.000664	0.000664	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—NRAS—bile duct cancer	0.000651	0.000651	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—TGFB1—bile duct cancer	0.000605	0.000605	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NRAS—bile duct cancer	0.000595	0.000595	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—EGFR—bile duct cancer	0.000593	0.000593	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—KRAS—bile duct cancer	0.00056	0.00056	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TGFB1—bile duct cancer	0.000553	0.000553	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—EGFR—bile duct cancer	0.000542	0.000542	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—NRAS—bile duct cancer	0.000521	0.000521	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—KRAS—bile duct cancer	0.000512	0.000512	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—IDH2—bile duct cancer	0.000492	0.000492	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—HRAS—bile duct cancer	0.000476	0.000476	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—EGFR—bile duct cancer	0.000475	0.000475	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—IL6—bile duct cancer	0.000456	0.000456	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TP53—bile duct cancer	0.000455	0.000455	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TGFBR2—bile duct cancer	0.000453	0.000453	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—KRAS—bile duct cancer	0.000448	0.000448	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TGFBR2—bile duct cancer	0.000443	0.000443	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—SLC5A5—bile duct cancer	0.000438	0.000438	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GNAS—bile duct cancer	0.000437	0.000437	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HRAS—bile duct cancer	0.000435	0.000435	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SMAD4—bile duct cancer	0.000429	0.000429	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GNAS—bile duct cancer	0.000428	0.000428	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—IDH1—bile duct cancer	0.000423	0.000423	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SMAD4—bile duct cancer	0.00042	0.00042	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL6—bile duct cancer	0.000416	0.000416	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.00041	0.00041	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ERBB2—bile duct cancer	0.000404	0.000404	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HRAS—bile duct cancer	0.000381	0.000381	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL6—bile duct cancer	0.000365	0.000365	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—bile duct cancer	0.000347	0.000347	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GNAS—bile duct cancer	0.00034	0.00034	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—NRAS—bile duct cancer	0.000309	0.000309	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NRAS—bile duct cancer	0.000308	0.000308	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—NRAS—bile duct cancer	0.000302	0.000302	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TGFB1—bile duct cancer	0.000286	0.000286	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—EGFR—bile duct cancer	0.000282	0.000282	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EGFR—bile duct cancer	0.00028	0.00028	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SLC5A5—bile duct cancer	0.000279	0.000279	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—EGFR—bile duct cancer	0.000276	0.000276	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—KRAS—bile duct cancer	0.000266	0.000266	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—KRAS—bile duct cancer	0.000265	0.000265	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000262	0.000262	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—KRAS—bile duct cancer	0.00026	0.00026	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ERBB2—bile duct cancer	0.00024	0.00024	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TP53—bile duct cancer	0.000235	0.000235	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ERBB2—bile duct cancer	0.000235	0.000235	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HRAS—bile duct cancer	0.000226	0.000226	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HRAS—bile duct cancer	0.000225	0.000225	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HRAS—bile duct cancer	0.000221	0.000221	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GNAS—bile duct cancer	0.000217	0.000217	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL6—bile duct cancer	0.000216	0.000216	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL6—bile duct cancer	0.000215	0.000215	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL6—bile duct cancer	0.000212	0.000212	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—bile duct cancer	0.000206	0.000206	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—bile duct cancer	0.000201	0.000201	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTGS2—bile duct cancer	0.000183	0.000183	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NRAS—bile duct cancer	0.000183	0.000183	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NRAS—bile duct cancer	0.000179	0.000179	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TGFB1—bile duct cancer	0.00017	0.00017	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EGFR—bile duct cancer	0.000166	0.000166	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TGFB1—bile duct cancer	0.000166	0.000166	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EGFR—bile duct cancer	0.000163	0.000163	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KRAS—bile duct cancer	0.000157	0.000157	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KRAS—bile duct cancer	0.000154	0.000154	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TP53—bile duct cancer	0.00014	0.00014	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TP53—bile duct cancer	0.000137	0.000137	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HRAS—bile duct cancer	0.000134	0.000134	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HRAS—bile duct cancer	0.000131	0.000131	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL6—bile duct cancer	0.000128	0.000128	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL6—bile duct cancer	0.000125	0.000125	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS2—bile duct cancer	0.000116	0.000116	CbGpPWpGaD
